Bone age in adolescents with schizophrenia and obsessive-compulsive disorder

Schizophrenia Research

Volumn 33, Issue 1-2, 1998, Pages 119-122

  Katz, Nachum ^a   Gothelf, Doron ^a   Hermesh, Haggai ^a,c   Weizman, Abraham ^a,c   Apter, Alan ^a,c   Horev, Gadi ^b,c  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bone age; Growth; Height; Obsessive compulsive disorder; Schizophrenia; Weight

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE AGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; OBSESSION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE DETERMINATION BY SKELETON; AGE FACTORS; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SCHIZOPHRENIA;

EID: 0032494264     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00055-3     Document Type: Article

References (12)

1. Apter, A., Orvaschel, H., Laseg, M., Moses, T., Tyano, S., 1989. Psychometric properties of the K-SADS-P in an Israeli adolescent inpatient population. J. Am. Acad. Child. Adolesc. Psychiatry 28, 61-65.
2. Fish, B., 1977. Neurologic antecedents of schizophrenia in children: evidence for an inherited, congenital neurointegrative defect. Arch. Gen. Psychiatry 34, 1297-1313.
3. Greulich, W.W., Pyle, S.I., 1964. Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd ed. Stanford University Press, Stanford, CA.
4. Hamburger, S.D., Swedo, S., Whitaker, A., Davies, M., Rapoport, J.L., 1989. Growth rate in adolescents with obsessive-compulsive disorder. Am. J. Psychiatry 146, 652-655.
5. Lewis, S.W., Murray, R.M., 1987. Obstetric complications, neurodevelopmental deviance, and schizophrenia. J. Psychiatr. Res. 21, 413-421.
6. McNeil, T.E., Cantor-Graae, E., Norstrom, L.G., Rosenlund, T., 1993. Head circumference in 'preschizophrenic' and control neonates. Br. J. Psychiatry 162, 517-523.
7. Meltzer, H.Y., Kolakowska, T., Fang, V.S., Fogg, L., Robertson, A., Lewine, R., Strahilevitz, M., Busch, D., 1984. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms. Arch. Gen. Psychiatry 41, 512-519.
8. Rifkin, L., Lewis, S., Jones, P., Toone, B., Murray, R., 1994. Low birth weight and schizophrenia. Br. J. Psychiatry 165, 357-362.
9. Sherman, L., Kim, S., Benjamin, F., Kolodny, H.D., 1971. Effects of chloropromazine on serum growth-hormone concentration in man. New Engl. J. Med. 284, 72-74.
10. Tanner, J.M., Whitehouse, R.H., 1976. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch. Dis. Childh. 51, 170-179.
11. Waddington, J.L., 1993. Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531-536.
12. Whalley, L.J., Christie, J.E., Brown, S., Arbuthnott, G.W., 1984. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine. Arch. Gen. Psychiatry 41, 1040-1043.